Skincare Devices Market Is Expected To Reach USD 12,799.5 Million By 2020: Grand View Research, Inc.

The Global Skincare Devices Market is expected to reach USD 12,799.5 million by 2020, growing at an estimated CAGR of 10.0% from 2014 to 2020, according to a new study by Grand View Research, Inc. Increasing prevalence of skin disorders and skin cancer around the globe is expected to drive skincare device demand. The growing demand of minimal, non-invasive and aesthetic procedures such as skin rejuvenation, skin tightening and body contouring is also expected to be a key driver of this market. In addition, rise in the growth of medical tourism and ‘Medspas’ in emerging markets such as India is expected to provide growth opportunities to market participants. Presence of cost effective procedures coupled with an abundant presence of English speaking healthcare practitioners are some of factors driving the market in these regions.
Skincare treatment devices dominated the product market with a share of over 92.0% in 2013. Change in consumer lifestyles and their growing willingness to spend on treatments such as liposuction, lasabrasion and Microdermabrasion to make favored body and skin modifications is expected to boost segment demand during the forecast period.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/skincare-devices-market

Further key findings from the study suggest:

• Skin tightening & body contouring segment is expected to grow at the highest CAGR of 12.0% during the forecast period. Rising disposable income of consumers and increasing desire to stay physically fit and attractive is one of the major factors accounting for its lucrative growth.

• The cellulite reduction market is also expected to grow at a significant pace during the forecast period. Growing global prevalence of obesity and the consequent rise in demand for cellulite (fat) reduction procedures is expected to drive segment growth during the forecast period.

• North America was the largest regional market in 2013, accounting for over 44.5% of global revenue due to rise in demand for skincare solutions to enhance physical features as a result of the modern lifestyle and increase in baby boomer population.

• Asia Pacific is expected to grow at the fastest CAGR of over 11.0% from 2014 to 2020. Improved health care facilities and an increasing preference for aesthetics related medical procedures coupled with growing disposable incomes will result in growth in demand for advanced skincare solutions in this region.

• Key industry participants of this market include Solta Medical Inc., Syneron Medical Ltd., Cynosure Inc., Cuttera Inc., Lumenis Ltd., Alma Lasers Ltd., and PhotMedex.

Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/skincare-devices-market/request

For the purpose of this study, Grand View Research has segmented the skincare devices market on the basis of product, application and region:
    • Skincare Devices Product Outlook
            • Skincare Diagnostic Device
                    • Dermatoscopes
                    • Image Guidance Systems
                    • Biopsy Devices
            • Skincare Treatment Devices
                    • Lasabrasion Devices Market
                    • LED Therapy Devices
                    • Liposuction Devices
                    • Microdermabrasion Devices
                    • Cryotherapy Devices
                    • Electrosurgical Devices
    • Skincare Devices Application Outlook
            • Disease Diagnosis & Treatment
            • Hair Removal Market
            • Skin Rejuvenation
            • Cellulite Reduction
            • Body Contouring And Skin Tightening
    • Skincare Market Regional Outlook
            • North America
            • Europe
            • Asia Pacific
            • RoW

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices

Bioinformatics Services Market Was Valued At USD 1.32 Billion In 2015 And Is Expected To Reach $4.1 Billion By 2024: Grand View Research, Inc.

Global bioinformatics services market is anticipated to reach USD 4.1 billion by 2024, according to a new report by Grand View Research, Inc. Growing adoption of I.T. solutions for different studies such as cell signaling, pathway metabolism, gene-receptor interactions, and target differentiation are expected to support growth in this market over the forecast period.
Owing to the benefits associated with the use of informatic solutions for laboratory protocol generation and data management as well as analysis, these solutions are projected to witness substantial demand in the coming years.
Moreover, collaborative activities undertaken by the information technology companies with pharmaceutical companies and clinical research organizations in order to develop and update key technologies linked to cloud computing, like online data storage and visualization of computer resources are expected to enhance market potential through to 2024.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/bioinformatics-services-market

Further key findings from the report suggest:

·         NGS is estimated to be the dominant segment with respect to the type of service served in 2015 owing to the fact that sequence-based approach of analysis can be cataloged with the structure-based approach as complementary to genomic and proteomic approaches. Advancement in the sequencing technologies such as NGS and scripting tools (Perl & Python) for sequence manipulation coupled with the reduction in prices of the sequencing platforms and market movement towards the USD 1,000 genome resulted in a larger revenue share of this segment in the discovery informatics.

·         Market revenue from of chemoinformatics is second only to NGS and its strong market position can be accounted for by presence of several entities operating in this segment and their involvement in the provision of lead identification, validation, assay development, lead generation, optimization, and clinical trial based informatic solutions.

·         Depending on the application, transcriptomics is anticipated to register the fastest growth of over 15% owing to rise in the number of projects carried out in translational research and application of RNA transcripts for studying etiology of chronic as well as acute diseases.

·         Academic sector, in terms of end-use for these services, is expected to witness the fastest growth through to 2024 as a result of rise in the adoption rate of these technologies in genomic, proteomic and metabolomics research programs carried out by universities research institutes. If not all, most of these programs are either backed through government funding or private corporation backing and forms a considerable part of the high R&D investment that the bioinformatics market attracts in the current scenario.

·         North America dominated the industry in 2015, accounting for a little 35% of total revenue. Presence of key participants operating in the region which are involved in development of novel algorithms and software in order to improve drug attrition rates which consequently increases adoption rate of computational algorithms is attributive for the largest share of North America in sector revenue. Demand for informatic services in Europe is also increasing owing to the presence of universities in Germany and UK that are involved in development of I.T. solutions for pharmaceutical research.

·         Asia Pacific is estimated to witness the fastest growth over the forecast period owing to the fact that government and regulatory authorities have implemented a framework to encourage R&D collaborations and framework extension. Active expansion strategies undertaken by a number of the major market entities operating in the American market in order to strengthen their position in Asia Pacific region is a factor anticipated to consequently drive growth.

·         Key players operating in this industry include Agilent technologies, Siegen Inc., GVK Biosciences, Accelerys Inc, Illumina Inc., DNAnexus, Life Technologies Corporation, Geneva Bioinformatic, Celera Corporation, IBM Life sciences, and Affymetrix.

·         These entities are adopting strategies such as collaborations with pharmaceutical and biotechnology companies in order to enhance industrial presence by providing different data management and analytical services for the purpose of drug design and therapeutic monitoring.

Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/bioinformatics-services-market/request

Grand View Research has segmented bioinformatics services market on the basis of service type, sector, application, and region:
Global Bioinformatics Services Outlook, by Type (Revenue, USD Million, 2013 - 2024)

·         NGS

·         Targeted Sequencing Analysis

·         Transcriptome Analysis

·         Whole Genome

·         Chip Seq Analysis

·         De novo Assembly

·         Methyl Seq Analysis

·         Cheminformatics

·         Sequence Analysis Platforms

·         Molecular Modeling

·         Docking

·         Clinical trial data management

·         Others

·         Microarray data analysis

·         Biological data curation

·         Scientific software testing

·         Other services

Global Bioinformatics Services Outlook, by Application (Revenue, USD Million, 2013 - 2024)

·         Genomics

·         Transcriptomics

·         Proteomics

·         Metabolomics

·         Drug Discovery

·         Others

Global Bioinformatics Services Outlook, by Sector (Revenue, USD Million, 2013 - 2024)

·         Medical

·         Animal

·         Agricultural

·         Academics

Bioinformatics Services Regional Outlook (Revenue, USD Million, 2013 - 2024)

·         North America

·         U.S.

·         Canada

·         Europe

·         Germany

·         UK

·         Asia Pacific

·         China

·         Japan

·         Latin America

·         Brazil

·         MEA

·         South Africa

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/biotechnology

Orthopedic Devices Market Is Expected To Reach USD 43.1 Billion By 2024, Will Grow Augmented Demand In Healthcare Industry: Grand View Research, Inc.

The global orthopedic devices market is expected to reach USD 43.1 billion by 2024, according to a new report published by Grand View Research, Inc. Major drivers of the market include the rising demand for orthopedic surgeries owing to the growth in road accidents and the prevalence of orthopedic diseases.
The introduction of new products made of materials, such as various types of ceramics and polymers, has led to a rise in the success rates of surgeries. In addition, these products are available at affordable costs and customizable sizes and shapes. As a result, the adoption of these advanced products is swiftly increasing. In addition, the rising geriatric population prone to orthopedic diseases, such as osteoporosis and arthritis, is augmenting the growth of the market.
Hip and knee applications together accounted for the largest market share in 2015. A relatively high rate of hip and knee replacement surgeries coupled with the constant innovations in the treatment of hip and knee injuries is contributing towards the growth of these application segments.
Stringent regulatory approval procedures are the prime factors restraining the growth of the market. In addition, a high device cost and expensive surgical costs are some other factors impeding the market growth.

View summary of this report @ http://www.grandviewresearch.com/industry-analysis/orthopedic-devices-market

Further key findings from the study suggest:

·         The knee orthopedic devices segment captured the largest share of the market in 2015. This was attributed to the factors such as a high rate of knee surgeries including common knee injuries to total knee replacements.

·         The hip orthopedic devices segment was the second largest market in 2015. The large portfolio for hip injury management is expected to result in a significant share in the global market.

·         North America captured the largest market share of 51.4% in 2015 and is expected to maintain its dominance over the forecast period. The presence of a large number of major market players and a high adoption rate of advanced technologies are the factors driving the growth of the market in the region.

·         The Asia Pacific market is expected to witness a lucrative CAGR of 8.6% during the forecast period. The presence of a large untapped market and the availability of supportive government regulations are expected to attract the attention of the global players.

·         Some major players in the orthopedic devices market include NuVasive, Inc., Medtronic PLC, Zimmer-Biomet Holdings, DePuySynthes, Stryker, Aesculap Implant Systems, LLC, Donjoy, Inc., and Conmed Corporation

Read detailed report or request for sample of this research report: - http://www.grandviewresearch.com/industry-analysis/orthopedic-devices-market/request

Grand View Research has segmented the orthopedic devices market on the basis of applications, product type and geography.
Orthopedic Devices, by Application, 2013 – 2024 (USD Million)

·         Hip Orthopedic Devices

·         Knee Orthopedic Devices

·         Spine Orthopedic Devices

·         Craniomaxillofacial Orthopedic Devices

·         Dental Orthopedic Devices

·         Sports Injuries, Extremities and Trauma(SET) Orthopedic Devices

Orthopedic Devices Market, by Product, 2013 – 2024 (USD Million)

·         Accessories

·         Braces

·         Consumables

·         Others

·         Surgical Devices  

·         Drill Guide

·         Guide Tubes

·         Implant Holder

·         Custom Clamps 

·         Distracters

·         Screw Drivers

·         Others     

Orthopedic devices market, by region, 2013 – 2024 (USD Million)

·         North America

·         U.S. Orthopedic Devices Market by Application Type

·         U.S. Orthopedic Devices Market by Product Type

·         Canada Orthopedic Devices Market by Application Type

·         Canada Orthopedic Devices Market by Product Type

·         Europe

·         UK Orthopedic Devices Market by Application Type

·         UK Orthopedic Devices Market by Product Type

·         Germany Orthopedic Devices Market by Application Type

·         Germany Orthopedic Devices Market by Product Type

·         Asia Pacific

·         Japan Orthopedic Devices Market by Application Type

·         Japan Orthopedic Devices Market by Product Type

·         China Orthopedic Devices Market by Application Type

·         China Orthopedic Devices Market by Product Type

·         Latin America

·         Brazil Orthopedic Devices Market by Application Type

·         Brazil Orthopedic Devices Market by Product Type

·         Mexico Orthopedic Devices Market by Application Type

·         Mexico Orthopedic Devices Market by Product Type

·         MEA

·         South Africa Orthopedic Devices Market by Application Type

·         South Africa Orthopedic Devices Market by Product Type

Browse more reports of this category by Grand View Research: http://www.grandviewresearch.com/industry/medical-devices